“announced that it has reached an agreement with the U.S. Food and Drug Administration or FDA on a Special Protocol Assessment (SPA) for its Phase III registration trial of Cx601 in the U.S. for the treatment of complex perianal fistulas in Crohn's disease patients.The agreed pivotal trial is a ra
“announced that it has reached an agreement with the U.S. Food and Drug Administration or FDA on a Special Protocol Assessment (SPA) for its Phase III registration trial of Cx601 in the U.S. for the treatment of complex perianal fistulas in Crohn's disease patients.The agreed pivotal trial is a ra
このブックマークにはスターがありません。
最初のスターをつけてみよう！
TiGenix Gets FDA's Endorsement Through SPA For Cx601 Phase III Trial In US
1 人がブックマーク・1 件のコメント
＼ コメントが サクサク読める アプリです ／